Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00556127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies
ClinicalTrials.gov study NCT00275431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03628053. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
ClinicalTrials.gov study NCT06346912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
ClinicalTrials.gov study NCT05336409. IPD Sharing: NO. Countries: 1. Publications: 0.
R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT00558220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma
ClinicalTrials.gov study NCT00880867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
ClinicalTrials.gov study NCT06213311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02670616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
ClinicalTrials.gov study NCT07270835. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)
ClinicalTrials.gov study NCT04148742. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05164770. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03664336. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT07030699. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (
ClinicalTrials.gov study NCT04970901. IPD Sharing: NO. Countries: 6. Publications: 0.
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT01729806. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER-2 B Cell Peptide Vaccine
ClinicalTrials.gov study NCT06414733. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01715961. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)
ClinicalTrials.gov study NCT04933825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms
ClinicalTrials.gov study NCT07200479. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.